Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-18T16:17:44.924Z Has data issue: false hasContentIssue false

PW01-264 - How Would European Trainees Treat Bipolar Disorder For Their Patients And Themselves, And What Influences Decision-Making?

Published online by Cambridge University Press:  17 April 2020

S. Jauhar
Affiliation:
Department of Psychiatry, Hairmyres Hospital, Glasgow
G. Lydall
Affiliation:
University College London, London, UK
F. Riese
Affiliation:
Zurich University Psychiatric Hospital, Zurich, Switzerland
J. Gama Marques
Affiliation:
Clinica Psiquiatrica II Centro, Lisbon, Portugal
M. Bendix
Affiliation:
Karolinska University Hospital, Stockholm, Sweden
O. Andlauer
Affiliation:
Université de Franche- Comté, Besançon, France
S. Gerber
Affiliation:
Dept of Psychiatry, Freiburg, Freiburg, Germany
N. De Vriendt
Affiliation:
Brugmann University Hospital, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium
I. Dumitrescu
Affiliation:
Bucharest University, Bucharest, Romania
A. Nawka
Affiliation:
Prague Psychiatric Centre and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic
S. Guloksuz
Affiliation:
Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Psychiatry Dept. Istanbul, Istanbul, Turkey
L. Mendonca
Affiliation:
Centro Hospitalar Psiquiatrico de Lisboa, Lisbon, Portugal
I. Nwachukw
Affiliation:
University College Dublin, Dublin, Ireland
R. Psaras
Affiliation:
Psychiatric Hospital of Attica, Athens, Greece
C. Roventa
Affiliation:
Department of Psychiatry, Bucharest, Bucharest, Romania
D. Giacco
Affiliation:
Dipartimento di Psichiatria, Università di Napoli SUN, Naples, Italy
A. Mufic
Affiliation:
Dept Psychiatry, Zagreb, Zagreb, Croatia
E. Dobrzynska
Affiliation:
Cygnet Hospital, Bristol, UK
A. Nazaraliev
Affiliation:
Department of Psychiatry, Moscow, Moscow, Russia
J. Van Zanten
Affiliation:
Vrije Universiteit Amsterdam Dept. of Psychiatry, Amsterdam, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives

Guidelines produced for management of Bipolar Disorder illustrate change in evidence-base for treatment of acute and maintenance phases of illness. Our Pan-European Research Group assessed clinical practice and desired treatments amongst amongst Psychiatry trainees.

Methods

A semi-structured survey was piloted, and homogenous sample size (at least 50) agreed upon from each country, with 50% minimum response rate. It was distributed via web-link, questioning preference of mood stabiliser for patients, trainees themselves and factors influencing choice.

Results

Tables 1 summarise choices.

Number (n)PercentageDrug(s)
263/22440.8/34.8Lithium
121/10118.8/15.7Semisodium Valproate
133/8520.7/13.2Sodium Valproate
21/503.3/7.8Lamotrigine
27/184.2/2.8Lithium and Sodium Valproate
10/151.6/2.3Carbamezapine
24/123.7/1.92nd Generation Atypical antipsychotics
8/41.2/0.7Various combinations
34/1345.3/21Left blank

[Choice of mood stabiliser for patient/themselves]

Factors influencing decision-making mapped onto cost, efficacy and side-effect profile (less than 4% other reasons). 66% (n=538) of respondents felt efficacy most important, 25% (n=202) felt side-effect profile most important and 3% (n=24) considered cost of most importance.

Conclusions

No clear difference exists in choice of mood stabiliser for European trainees and their patients, and decisions based on perceived efficacy are generally in keeping with established guidelines.

Type
Psychopharmacological treatment and biological therapies
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.